Armistice Capital’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-148,800
Closed -$8.26M 74
2018
Q4
$8.26M Buy
+148,800
New +$8.26M 0.63% 31